Agios Pharmaceuticals Inc
NASDAQ:AGIO

Watchlist Manager
Agios Pharmaceuticals Inc Logo
Agios Pharmaceuticals Inc
NASDAQ:AGIO
Watchlist
Price: 32.09 USD 0.79% Market Closed
Market Cap: 1.9B USD

Intrinsic Value

AGIO's intrinsic value estimate is unreliable because it is based only on its multiples and doesn't use a DCF valuation.

The intrinsic value of one AGIO stock under the Base Case scenario is 28.79 USD. Compared to the current market price of 32.09 USD, Agios Pharmaceuticals Inc is Overvalued by 10%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

AGIO Intrinsic Value
28.79 USD
Overvaluation 10%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Agios Pharmaceuticals Inc

Valuation History Unavailable

Historical valuation for AGIO cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
0%

Fundamental Analysis

Company Overview
Loading...
Business Segments
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
AI Assistant
AI Assistant
Ask me anything about Agios Pharmaceuticals Inc
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Agios Pharmaceuticals Inc

Current Assets 968.6m
Cash & Short-Term Investments 893.4m
Receivables 3.3m
Other Current Assets 71.9m
Non-Current Assets 586.9m
Long-Term Investments 531.3m
PP&E 50.9m
Other Non-Current Assets 4.7m
Efficiency

Free Cash Flow Analysis
Agios Pharmaceuticals Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Agios Pharmaceuticals Inc

Revenue
37m USD
Cost of Revenue
-4.6m USD
Gross Profit
32.4m USD
Operating Expenses
616.4m USD
Operating Income
648.8m USD
Other Expenses
17.1m USD
Net Income
666m USD
Fundamental Scores

AGIO Profitability Score
Profitability Due Diligence

Agios Pharmaceuticals Inc's profitability score is 51/100. The higher the profitability score, the more profitable the company is.

Exceptional 3-Years Revenue Growth
Positive Gross Profit
Exceptional Revenue Growth Forecast
Exceptional ROE
51/100
Profitability
Score

Agios Pharmaceuticals Inc's profitability score is 51/100. The higher the profitability score, the more profitable the company is.

AGIO Solvency Score
Solvency Due Diligence

Agios Pharmaceuticals Inc's solvency score is 81/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
Low D/E
81/100
Solvency
Score

Agios Pharmaceuticals Inc's solvency score is 81/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

AGIO Price Targets Summary
Agios Pharmaceuticals Inc

Wall Street analysts forecast AGIO stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for AGIO is 56.44 USD with a low forecast of 38.38 USD and a high forecast of 77.7 USD.

Lowest
Price Target
38.38 USD
20% Upside
Average
Price Target
56.44 USD
76% Upside
Highest
Price Target
77.7 USD
142% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Agios Pharmaceuticals Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for AGIO is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

AGIO Insider Trading
Buy and sell transactions by insiders

AGIO News

Other Videos
What is the Intrinsic Value of one AGIO stock?

The intrinsic value of one AGIO stock under the Base Case scenario is 28.79 USD.

Is AGIO stock undervalued or overvalued?

Compared to the current market price of 32.09 USD, Agios Pharmaceuticals Inc is Overvalued by 10%.

Back to Top